Skip to main content
PMC home page
Journal of Cellular and Molecular Medicine logoLink to Journal of Cellular and Molecular Medicine
. 2007 May 1;9(3):670–682. doi: 10.1111/j.1582-4934.2005.tb00497.x

Peroxisome proliferator ‐ activated receptor γ overexpression inhibits pro‐fibrogenic activities of immortalised rat pancreatic stellate cells

Robert Jaster 1,✉, Philipp Lichte 1, Brit Fitzner 1, Peter Brock 1, Änne Glass 2, Thomas Karopka 2, Lothar Gierl 2, Dirk Koczan 3, Hans‐Jürgen Thiesen 3, Gisela Sparmann 1, Jörg Emmrich 1, Stefan Liebe 1
PMCID: PMC6741639  PMID: 16202214

Abstract

Pancreatic stellate cells (PSCs) play a key role in the development of pancreatic fibrosis, a constant feature of chronic pancreatitis and pancreatic cancer. In response to pro‐fibrogenic mediators, PSCs undergo an activation process that involves proliferation, enhanced production of extracellular matrix proteins and a phenotypic transition towards myofibroblasts. Ligands of the peroxisome proliferator‐activated receptor gamma (PPARγ), such as thiazolidinediones, are potent inhibitors of stellate cell activation and fibrogenesis in pancreas and liver. The effects of PPARγ ligands, however, however, are at least in part mediated through PPARγ‐independent pathways. Here, we have chosen a different approach to study regulatory functions of PPARγ in PSCs. Using immortalised rat PSCs, we have established a model of tetracycline (tet)‐regulated PPARγ over‐expression. Induction of PPARγ expression strongly inhibited proliferation and enhanced the rate of apoptotic cell death. Furthermore, PPARγ‐overexpressing cells synthesised less collagen than controls. To monitor effects of PPARγ on PSC gene expression, we employed Affymetrix microarray technology. Using stringent selection criteria, we identified 21 up‐ and 19 down‐regualated genes in PPARγ‐overexpressing cells. Most of the corresponding gene products are either involved in lipid metabolism, play a role in signal transduction, or are secreted molecules that regulate cell growth and differentition. In conclusion, our data suggest an active role of PPARγ in the induction of a quiescent PSC phenotype. PPARγ‐regulated genes in PSCs may serve as novel targets for the development of antifibrotic therapies.

Keywords: pancreatic stellate cells, fibrosis, peroxisome proliferator‐activated receptor γ

References

  • 1. Bachem MG, Schneider E, Groß H, Weidenbach H, Schmid RM, Menke A, Siech M, Beger H, Grünert A, Adler G. Identification, culture, and characterisation of pancreatic stellate cells in rats and humans. Gastroenterology 1998; 115: 421–32. [DOI] [PubMed] [Google Scholar]
  • 2. Apte MV, Haber PS, Applegate TL, Norton ID, McCaughan GW, Korsten MA, Pirola RC, Wilson JS. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 1998; 43: 128–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Haber PS, Keogh GW, Apte MV, Moran CS, Stewart NL, Crawford DHG, Pirola RC, McCaughan GW, Ramm GA, Wilson JS. Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol. 1999; 155: 1087–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Apte MV, Park S, Phillips PA, Santucci N, Goldstein D, Kumar RK, Ramm GA, Buchler M, Friess H, McCarroll JA, Keogh G, Merrett N, Pirola R, Wilson JS. Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas 2004; 29: 179–87. [DOI] [PubMed] [Google Scholar]
  • 5. Sparmann G, Hohenadl C, Tornoe J, Jaster R, Fitzner B, Koczan D, Thiesen HJ, Glass Ä, Winder D, Liebe S, Emmrich J. Generation and characterization of immor talised rat pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2004; 287: G211–9. [DOI] [PubMed] [Google Scholar]
  • 6. Spiegelman BM, Flier JS. Adipogenesis and obesity: rounding out the big picture. Cell 1996; 87: 377–89. [DOI] [PubMed] [Google Scholar]
  • 7. Masamune A, Kikuta K, Satoh M, Sakai Y, Satoh A, Shimosegawa TJ. Ligands of peroxisome proliferator‐activated receptor‐? block activation of pancreatic stellate cells. Biol Chem. 2002; 277: 141–7. [DOI] [PubMed] [Google Scholar]
  • 8. Galli A, Crabb D, Price D, Ceni E, Salzano R, Surrenti C, Casini A. Peroxisome proliferator‐activated receptor transcriptional regulation is involved in platelet‐derived growth factor‐induced proliferation of human hepatic stellate cells. Hepatology 2000; 31: 101–8. [DOI] [PubMed] [Google Scholar]
  • 9. Marra F, Efsen E, Romanelli RG, Caligiuri A, Pastacaldi S, Batignani G, Bonacchi A, Caporale R, Laffi G, Pinzani M, Gentilini P. Ligands of peroxisome proliferator‐activated receptor? modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 2000; 119: 466–78. [DOI] [PubMed] [Google Scholar]
  • 10. Galli A, Crabb DW, Ceni E, Salzano R, Mello T, Svegliati‐Baroni G, Ridolfi F, Trozzi L, Surreni C, Casini A. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro . Gastroenterology 2002; 122: 1924–40. [DOI] [PubMed] [Google Scholar]
  • 11. Miyahara T, Schrum L, Rippe R, Xiong S, Yee HF Jr, Motomura K, Anania FA, Willson TM, Tsukamoto H. Peroxisome proliferator‐activated receptors and hepatic stellate cell activation. J Biol Chem. 2000; 275: 35715–22. [DOI] [PubMed] [Google Scholar]
  • 12. Shimizu K, Shiratori K, Hayashi N, Kobayashi M, Fujiwara T, Horikoshi H. Thiazolidinedione derivates as novel therapeutic agents to prevent the development of chronic pancreatitis. Pancreas 2002; 24: 184–90. [DOI] [PubMed] [Google Scholar]
  • 13. Shimizu K, Shiratori K, Kobayashi M, Kawamata H. Troglitazone inhibits the progression of chronic pancreatitis and the profibrogenic activity of pancreatic stellate cells via a PPARγ‐independent mechanism. Pancreas 2004; 29: 67–74. [DOI] [PubMed] [Google Scholar]
  • 14. Park EJ, Park SY, Joe EH, Jou I. 15d‐PGJ2 and rosigli‐tazone suppress Janus kinase‐STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in Glia. J Biol Chem. 2003; 278: 14747–52. [DOI] [PubMed] [Google Scholar]
  • 15. Baek SJ, Wilson LC, His LC, Eling TE. Troglitazone, a peroxisome proliferator‐activated receptor γ (PPARγ) ligand, selectively induces the early growth response‐1 gene independently of PPARγ. A novel mechanism for its anti‐tumorigenic activity. J Biol Chem. 2003; 278: 5845–53. [DOI] [PubMed] [Google Scholar]
  • 16. Hinz B, Brune K, Pahl A. 15‐Deoxy‐Δ(12,14)‐prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR‐γ‐independent mechanism. Biochem Biophys Res Commun 2003; 302: 415–20. [DOI] [PubMed] [Google Scholar]
  • 17. Parameswaran N, Hall CS, Bomberger JM, Sparks HV, Jump DB, Spielman WS. Negative growth effects of ciglitazone on kidney interstitial fibroblasts: role of PPARγ. Kidney Blood Press Res. 2003; 26: 2–9. [DOI] [PubMed] [Google Scholar]
  • 18. Hazra S, Xiong S, Wang J, Rippe RA, Krishna V, Chatterjee K, Tsukamoto H. Peroxisome proliferator‐activated receptor γ induces a phenotypic switch from activated to quiescent hepatic stellate cells. J Biol Chem. 2004; 279: 11392–401. [DOI] [PubMed] [Google Scholar]
  • 19. Jaster R, Sparmann G, Emmrich J, Liebe S. Extracellular signal‐regulated kinases are key mediators of mitogenic signals in rat pancreatic stellate cells. Gut 2002; 51: 579–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Sparmann G, Behrend S, Merkord J, Kleine, HD , Graser E, Ritter T, Liebe S, Emmrich J. Cytokine mRNA levels and lymphocyte infiltration in pancreatic tissue during experimental chronic pancreatitis induced by dibutyltin dichloride. Dig Dis Sci. 2001; 46: 1647–56. [DOI] [PubMed] [Google Scholar]
  • 21. Jaster R, Hilgendorf I, Fitzner B, Brock P, Sparmann G, Emmrich J, Liebe S. Regulation of pancreatic stellate cell function in vitro: biological and molecular effects of all‐trans retinoic acid. Biochem Pharmacol. 2003; 66: 633–41. [DOI] [PubMed] [Google Scholar]
  • 22. Iruela‐Arispe ML, Carpizo D, Luque A. ADAMTS1: a matrix metalloprotease with angioinhibitory properties. Ann NY Acad Sci 2003; 1995: 183–90. [DOI] [PubMed] [Google Scholar]
  • 23. Rosen ED, Spiegelman BM. PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem. 2001; 276: 37731–4. [DOI] [PubMed] [Google Scholar]
  • 24. Iida KT, Kawakami Y, Suzuki H, Sone H, Shimano H, Toyoshima H, Okuda Y, Yamada N. PPARγ lig‐ands, troglitazone and pioglitazone, up‐regulate expression of HMG‐CoA synthase and HMG‐CoA reductase gene in THP‐1 macrophages. FEBS Lett. 2002; 520: 177–81. [DOI] [PubMed] [Google Scholar]
  • 25. Albrektsen T, Fleckner J. The transcription factor Fos‐related antigen 1 is induced by thiazolidinediones during differentiation of 3T3–L1 cells. Mol Pharmacol. 2001; 59: 567–75. [DOI] [PubMed] [Google Scholar]
  • 26. Lapsys NM, Kriketos AD, Lim‐Fraser M, Poynten AM, Lowy A, Furler SM, Chisholm DJ, Cooney GJ. Expression of genes involved in lipid metabolism correlate with peroxisome proliferator‐activated receptor gamma expression in human skeletal muscle. J Clin Endocrinol Metab. 2000; 85: 4293–7. [DOI] [PubMed] [Google Scholar]
  • 27. Singh Ahuja H, Liu S, Crombie DL, Boehm M, Leibowitz MD, Heyman RA, Depre C, Nagy L, Tontonoz P, Davies P. Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents. Mol Pharmacol. 2001; 59: 765–73. [DOI] [PubMed] [Google Scholar]
  • 28. Marx N, Bourcier T, Sukhova GK, Libby P, Plutzky J. PPARγ activation in human endothelial cells increases plasminogen activator inhibitor type‐1 expression: PPARγ as a potential mediator in vascular disease. Arterioscler Thromb Vasc Biol. 1999; 19: 546–51. [DOI] [PubMed] [Google Scholar]
  • 29. Iglarz M, Touyz RM, Viel EC, Paradis P, Amiri F, Diep QN, Schiffrin EL. Peroxisome proliferator‐activated receptor‐α and receptor‐γ activators prevent cardiac fibrosis in mineralocorticoid‐dependent hypertension. Hypertension 2003; 42: 737–43. [DOI] [PubMed] [Google Scholar]
  • 30. Martin‐Nizard F, Furman C, Delerive P, Kandoussi A, Fruchart JC, Staels B, Duriez P. Peroxisome pro‐liferator‐activated receptor activators inhibit oxidized low‐density lipoprotein‐induced endothelin‐1 secretion in endothelial cells. J Cardiovasc Pharmacol. 2002; 40: 822–31. [DOI] [PubMed] [Google Scholar]
  • 31. Sakai S, Miyauchi T, Irukayama‐Tomobe Y, Ogata T, Goto K, Yamaguchi I. Peroxisome proliferator‐activated receptor‐γ activators inhibit endothelin‐1–related cardiac hypertrophy in rats. Clin Sci. 2002; 103: 16S–20S. [DOI] [PubMed] [Google Scholar]
  • 32. Guo CY, Wu JY, Wu YB, Zhong MZ, Lu HM. Effects of endothelin‐1 on hepatic stellate cell proliferation, collagen synthesis and secretion, intracellular free calcium concentration. World J Gastroenterol. 2004; 10: 2697–700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Klonowski‐Stumpe H, Reinehr R, Fischer R, Warskulat U, Luthen R, Haussinger D. Production and effects of endothelin‐1 in rat pancreatic stellate cells. Pancreas 2003; 27: 67–74. [DOI] [PubMed] [Google Scholar]
  • 34. Wada W, Kuwano H, Hasegawa Y, Kojima I. The dependence of transforming growth factor‐β‐induced collagen production on autocrine factor activin A in hepatic stellate cells. Endocrinology 2004; 145: 2753–9. [DOI] [PubMed] [Google Scholar]
  • 35. Ohnishi N, Miyata T, Ohnishi H, Yasuda H, Tamada K, Ueda N, Mashima H, Sugano K. Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis. Gut 2003; 52: 1487–93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Na HK, Surh YJ. Peroxisome proliferator‐activated receptor γ (PPARγ) ligands as bifunctional regulators of cell proliferation. Biochem Pharmacol 2003; 66: 1381–91. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Cellular and Molecular Medicine are provided here courtesy of Blackwell Publishing

RESOURCES